123 related articles for article (PubMed ID: 23740895)
1. One is better than two: TCR pairing and GVHD.
Vincent BG; Serody JS
Sci Transl Med; 2013 Jun; 5(188):188fs21. PubMed ID: 23740895
[TBL] [Abstract][Full Text] [Related]
2. Dual receptor T cells mediate pathologic alloreactivity in patients with acute graft-versus-host disease.
Morris GP; Uy GL; Donermeyer D; Dipersio JF; Allen PM
Sci Transl Med; 2013 Jun; 5(188):188ra74. PubMed ID: 23740900
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of T-cell receptor repertoire in bone marrow transplant recipients: evidence for oligoclonal T-cell expansion in graft-versus-host disease lesions.
Liu X; Chesnokova V; Forman SJ; Diamond DJ
Blood; 1996 Apr; 87(7):3032-44. PubMed ID: 8639927
[TBL] [Abstract][Full Text] [Related]
4. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
[TBL] [Abstract][Full Text] [Related]
5. The highly alloreactive nature of dual TCR T cells.
Balakrishnan A; Morris GP
Curr Opin Organ Transplant; 2016 Feb; 21(1):22-8. PubMed ID: 26555233
[TBL] [Abstract][Full Text] [Related]
6. CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL.
Matte-Martone C; Liu J; Jain D; McNiff J; Shlomchik WD
Blood; 2008 Apr; 111(7):3884-92. PubMed ID: 18223170
[TBL] [Abstract][Full Text] [Related]
7. Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation.
Imamura M; Tsutsumi Y; Miura Y; Toubai T; Tanaka J
Hematology; 2003 Feb; 8(1):19-26. PubMed ID: 12623423
[TBL] [Abstract][Full Text] [Related]
8. Distinct oligoclonal T cells are associated with graft versus host disease after stem-cell transplantation.
Berrie JL; Kmieciak M; Sabo RT; Roberts CH; Idowu MO; Mallory K; Chung HM; McCarty JM; Borrelli CA; Detwiler MM; Kazim AL; Toor AA; Manjili MH
Transplantation; 2012 May; 93(9):949-57. PubMed ID: 22377792
[TBL] [Abstract][Full Text] [Related]
9. TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Du JW; Gu JY; Liu J; Cen XN; Zhang Y; Ou Y; Chu B; Zhu P
Leuk Lymphoma; 2007 Aug; 48(8):1618-27. PubMed ID: 17701594
[TBL] [Abstract][Full Text] [Related]
10. Different T-cell receptor repertoires between lesions and peripheral blood in acute graft-versus-host disease after allogeneic bone marrow transplantation.
Kubo K; Yamanaka K; Kiyoi H; Fukutani H; Ito M; Hayakawa R; Ohno R; Naoe T
Blood; 1996 Apr; 87(7):3019-26. PubMed ID: 8639925
[TBL] [Abstract][Full Text] [Related]
11. Donor Allospecific CD44
Huang W; Mo W; Jiang J; Chao NJ; Chen BJ
Front Immunol; 2019; 10():624. PubMed ID: 31001254
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.
Miura Y; Thoburn CJ; Bright EC; Sommer M; Lefell S; Ueda M; Nakao S; Hess AD
Blood; 2001 Aug; 98(3):868-76. PubMed ID: 11468190
[TBL] [Abstract][Full Text] [Related]
13. Targeting Signal 3 Extracellularly and Intracellularly in Graft-Versus-Host Disease.
Kim S; Reddy P
Front Immunol; 2020; 11():722. PubMed ID: 32411139
[TBL] [Abstract][Full Text] [Related]
14. Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells.
Yu XZ; Albert MH; Anasetti C
J Immunol; 2006 Mar; 176(6):3383-90. PubMed ID: 16517706
[TBL] [Abstract][Full Text] [Related]
15. Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Barrett TA; Bluestone JA; Vallera DA
Blood; 1996 Jan; 87(2):827-37. PubMed ID: 8555509
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells.
Koestner W; Hapke M; Herbst J; Klein C; Welte K; Fruehauf J; Flatley A; Vignali DA; Hardtke-Wolenski M; Jaeckel E; Blazar BR; Sauer MG
Blood; 2011 Jan; 117(3):1030-41. PubMed ID: 21063028
[TBL] [Abstract][Full Text] [Related]
17. Acute graft-vs-host disease: pathobiology and management.
Goker H; Haznedaroglu IC; Chao NJ
Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
[TBL] [Abstract][Full Text] [Related]
18. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.
Hirokawa M; Matsutani T; Saitoh H; Ichikawa Y; Kawabata Y; Horiuchi T; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB; Sawada K
Bone Marrow Transplant; 2002 Dec; 30(12):915-23. PubMed ID: 12476285
[TBL] [Abstract][Full Text] [Related]
19. Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.
Bendle GM; Linnemann C; Hooijkaas AI; Bies L; de Witte MA; Jorritsma A; Kaiser AD; Pouw N; Debets R; Kieback E; Uckert W; Song JY; Haanen JB; Schumacher TN
Nat Med; 2010 May; 16(5):565-70, 1p following 570. PubMed ID: 20400962
[TBL] [Abstract][Full Text] [Related]
20. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
Orsini E; Alyea EP; Schlossman R; Canning C; Soiffer RJ; Chillemi A; Neuberg D; Anderson KC; Ritz J
Bone Marrow Transplant; 2000 Mar; 25(6):623-32. PubMed ID: 10734296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
